Improving T cell killing and understanding senescence: Possible roles for TP53 in cancer immunotherapy

Proc Natl Acad Sci U S A. 2024 Mar 19;121(12):e2402533121. doi: 10.1073/pnas.2402533121. Epub 2024 Mar 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cell Death
  • Cell- and Tissue-Based Therapy
  • Humans
  • Immunotherapy
  • Neoplasms* / genetics
  • Neoplasms* / therapy
  • Receptors, Chimeric Antigen*
  • T-Lymphocytes
  • Tumor Suppressor Protein p53 / genetics

Substances

  • Receptors, Chimeric Antigen
  • Tumor Suppressor Protein p53
  • TP53 protein, human